Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT01879956
Eligibility Criteria:
Inclusion Criteria:
* Pacients with diagnosis of schizophrenia for DMS IV-R.
* Pacients that signed the consent in writing and receive explanations about the nature of the study.
* Patients who carefully counted another responsible person to provide reliable support to the patient and ensure adherence to the same study treatment.
* Patients with minimum education: five years (elementary school).
* Patients who present rates below those expected for their age group in at least 3 of the executive functions assessed on neuropsychological tests, and evaluation of executive functions.
* Patients with stable clozapine and which have not been recently admitted (3 months).
Exclusion Criteria:
* Comorbid diagnosis of substance dependence or other psychiatric Axis I;
* History of head trauma and / or other neurological problems;
* Medical problems that compromise somehow the central nervous system;
* History of mental retardation;
* Patients treated with medication other than clozapine;
* Patients who are suffering other psychosocial treatments.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01879956
Study Brief:
Protocol Section:
NCT01879956